Medicine and Healthnpj Science of Food
A probiotic *Limosilactobacillus fermentum* GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome
T. Zhou, J. Wu, et al.
This groundbreaking study reveals the potential of the probiotic Limosilactobacillus fermentum GR-3 in combating colitis-associated tumorigenesis in mice. With a notable 51.2% reduction in tumor incidence, this research showcases the powerful health benefits of gut microbiome modulation, led by an expert team from Lanzhou University and Augusta University.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Exercise mitigates a gut microbiota-mediated reduction in adult hippocampal neurogenesis and associated behaviours in rats
S. Nicolas, S. Dohm-hansen, et al.
Food Science and Technology
Obesity, but not high-fat diet, is associated with bone loss that is reversed via CD4+CD25+Foxp3+ Tregs-mediated gut microbiome of non-obese mice
W. Song, Q. Sheng, et al.
Health and Fitness
Stronger gut microbiome modulatory effects by postbiotics than probiotics in a mouse colitis model
T. Zhang, W. Zhang, et al.
Medicine and Health
Orexin-A and endocannabinoids are involved in obesity-associated alteration of hippocampal neurogenesis, plasticity, and episodic memory in mice
N. Forte, S. Boccella, et al.
